StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Earnings

Nu-Med Plus's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Nu-Med Plus's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Nu-Med Plus has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Nu-Med Plus puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Nu-Med Plus filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?